Inphi reports strong fourth quarter revenue growth
Semiconductor producer Inphi, which has operations in Westlake Village, reported fourth quarter net income of $19.1 million, or 42 cents per diluted share, bringing the company to $26.5 million in net income for its fiscal year 2016. Revenues from continuing operations rose 53 percent, from $52.9 million in the fourth quarter of 2015 to $80.9 Read More →
Merger of San Luis Obispo tech companies soured by lawsuit
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Semtech’s LoRa spreads wide net around the globe
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
QAD’s Lopker charted her own path to success
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen beats analyst estimates for fourth quarter revenue
Thousand Oaks-based biotech giant Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing 8 percent from the fourth quarter of 2015. The world’s largest biotech drug maker posted total revenues of $23 billion on the year, up 6 percent from 2015. Revenue gains were Read More →
Teledyne Technologies reports decline in net income
Thousand-Oaks based Teledyne Technologies reported a drop in net income for its fiscal year 2016 over the prior year, with a 7 percent fourth quarter drop in sales to $552.9 million. Net income from continuing operations came to $192.9 million, or $5.43 per diluted share, compared to $198 million in 2015, while total sales fell Read More →
Agilent cancer treatment approved in Europe
Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →
